Tufton Capital Management’s VanEck Biotech ETF BBH Stock Holding History

Tufton Capital Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,250	Closed	-$219K	–	127
2021 Q1	$219K	Sell	1,250 -300	-19%	-$54.2K	0.04%	120
2020 Q4	$263K	Hold	1,550	–	–	0.05%	110
2020 Q3	$251K	Hold	1,550	–	–	0.05%	109
2020 Q2	$252K	Sell	1,550 -100	-6%	-$15.2K	0.06%	105
2020 Q1	$211K	Hold	1,650	–	–	0.05%	105
2019 Q4	$230K	Buy	+1,650	New	+$217K	0.05%	111
2019 Q3	–	Sell	-1,650	Closed	-$212K	–	119
2019 Q2	$212K	Hold	1,650	–	–	0.04%	120
2019 Q1	$212K	Buy	+1,650	New	+$208K	0.05%	116
2018 Q4	–	Sell	-1,850	Closed	-$251K	–	119
2018 Q3	$251K	Hold	1,850	–	–	0.05%	113
2018 Q2	$221K	Sell	1,850 -800	-30%	-$94.3K	0.05%	115
2018 Q1	$318K	Hold	2,650	–	–	0.06%	103
2017 Q4	$330K	Hold	2,650	–	–	0.06%	106
2017 Q3	$355K	Hold	2,650	–	–	0.07%	102
2017 Q2	$333K	Hold	2,650	–	–	0.07%	96
2017 Q1	$315K	Buy	+2,650	New	+$310K	0.06%	98

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Tufton Capital Management's BBH Position: Q2 2021 in Review

Tufton Capital Management sold out of VanEck Biotech ETF (BBH) in Q2 2021, closing a stake of 1,250 shares — an estimated $219K sold.

Tufton Capital Management first reported a position in BBH in Q1 2017 and held it in 15 quarters. The position peaked at $355K in Q3 2017. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2021.

Tufton Capital Management reported no remaining VanEck Biotech ETF position as of Q2 2021 after selling out during the quarter.
Tufton Capital Management sold 1,250 VanEck Biotech ETF shares in Q2 2021, an estimated $219K.
Tufton Capital Management first reported a position in VanEck Biotech ETF in Q1 2017 and held it in 15 quarters.
Tufton Capital Management's VanEck Biotech ETF position peaked at $355K in Q3 2017.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2021.

Based on Tufton Capital Management's 13F filing for Q2 2021, filed 29 Jul 2021.